期刊文献+

卡维地洛治疗扩张型心肌病心力衰竭患者的疗效 被引量:8

Therapeutic effect of carvedilol on patients with dilated cardiomyopathy and heart failure
下载PDF
导出
摘要 目的:观察卡维地洛治疗扩张型心肌病心力衰竭患者的临床疗效。方法:选择扩张型心肌病心力衰竭患者82例,采用随机分组的方法分为卡维地洛组(42例)和常规治疗组(40例),卡维地洛组在常规治疗基础上加用卡维地洛3.125~25mg2次/d。比较两组左室舒张期末内径(LVEDd)、左室收缩期末内径(LVEsd)、左房内径(LAD)、左室射血分数(LVEF)、6min步行距离(6MWD)等指标变化情况。结果:治疗6个月后,两组患者心功能均有改善,卡维地洛组总有效率显著高于常规治疗组(90.5%比72.5%,P〈0.05);两组治疗后患者的LVEDd、LVESd、LVEF及6MWD均有显著改善(P〈0.05),且与常规治疗组比较,卡维地洛组治疗后患者的LVEDd[(59.1±9.6)mm比(54.2±10.2)mm]、LVESd[(46.1±8.7)mm比(41.4±12.2)mm]显著缩小,LVEF[(42.1±10.5)%比(48.4±9.6)%]及6MWD[(264.52±51.23)m比(309.26±45.24)m]显著增加(P均〈0.05)。结论:在常规治疗基础上加用卡维地洛可明显改善扩张型心肌病心力衰竭患者的疗效。 Objective: To observe therapeutic effect of carvedilol on patients with dilated cardiomyopathy (DCM) and heart failure (HF). Methods: A total of 82 cases with DCM and HF were selected. They were randomly divided into carvedilol group (n = 42) and routine treatment group (n = 40). Patients in carvedilol group received carvedilol 3. 125-25 mg twice/d based on routine treatment. Changes of left ventricular end-diastolic dimension (LVEDd), left ventricular end-systolic dimension (LVESd), left atrial diameter (LAD), left ventricular ejection fraction (LVEF), 6 min walking distance (6MWD) were compared between two groups. Results: After six-month treat-ment, there was significant improvement in cardiac function in both groups, and total effective rate of carvedilol group (90.5%) was significantly higher than that of routine treatment group (72.5%), P〈0.05; Compared with routine treatment group, there were significant decrease in LVEDd [ (59.1 ± 9.6) mm vs. (54.2 ± 10.2) mm], LVESd [ (46.1 ± 8.7) mm vs. (41.4± 12.2) mm] and significant increase in LVEF [ (42.1± 10.5)% vs. (48.4 ± 9.6) %] and 6 MWD [ (264.52 ± 51.23) m vs. (309.26 ± 45.24) m] in carvedilol group, P〈0.05 all. Conclu-sion: Application of carvedilol based on routine treatment can significantly improve therapeutic effect of patients with dilated cardiomyopathy and heart failure.
作者 杨龙
出处 《心血管康复医学杂志》 CAS 2013年第5期494-496,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 卡维地洛 心肌病 扩张型 心力衰竭 充血性 Carvedilol Cardiomyopathy, dilated Heart failure, congestive
  • 相关文献

参考文献10

  • 1顾东风,黄广勇,吴锡桂,段秀芳,何江,Paul K Whelton,Stephen Mac Mahon.中国心力衰竭流行病学调查及其患病率[J].中华心血管病杂志,2003,31(1):3-6. 被引量:1278
  • 2Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms inpatients with idiopath- ic dilated cardiomyopathy [J]. Circulation, 2003, 108 (7): 839 -843. 被引量:1
  • 3无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3697
  • 4戴闺柱.心力衰竭治疗概念的转变——“负性肌力药”β-受体阻滞剂的常规应用[J].临床心血管病杂志,2003,19(6):321-322. 被引量:68
  • 5Wa/~gstein F. Adrenergic beta-blocking agents in congesive heart failure due to idiopathic dilated cardiomyopathy [J]. Eur Heart J, 1995, 16 (Supp10) : S128-S132. 被引量:1
  • 6Tominaga M, Matsumori A, Okada I, et al. Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice [J]. Circulation, 1991, 83 (6): 2021-2028. 被引量:1
  • 7Hjalamarson A, Waagstein F. The role of beta-blockers in the treatment of catdiomyopatby and iscbaemic heart failure [J]. Drugs, 1994, 47 (Suppl4) : 39-40. 被引量:1
  • 8Magnusson Y, Marullo S, Hoyer S, et al. Mapping of a func- tional autoimmune epitope on the betal-adrenergic receptor in pa- tients with idiopathic dilated cardiomyopathy [J]. J Clin Invest, 1990, 86 (5): 1658-1663. 被引量:1
  • 9Swedherg K. Initial experience with beta-blockers in dilated cardiomyopathy [J]. AmJ Cardiol, 1993, 71 (9) ; 30C-38C. 被引量:1
  • 10Castro P, Vukasovi c JL, Chiong M, et al. Effects of carvedilol on oxidative stress and chronotropic response to exercise in pa- tients with chronic heart failure [J]. Eur J Heart Fail. 2005, 7 (6) : 1033-1039. 被引量:1

二级参考文献43

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2叶任高 主编.内科学:第5版[M].北京:人民卫生出版社,2001.824. 被引量:158
  • 3Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L 被引量:1
  • 4Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23. 被引量:1
  • 5Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235. 被引量:1
  • 6Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140. 被引量:1
  • 7Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45. 被引量:1
  • 8Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2. 被引量:1
  • 9Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387. 被引量:1
  • 10Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274. 被引量:1

共引文献4919

同被引文献73

引证文献8

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部